|
|
Volumn 1, Issue 7, 2010, Pages 472-482
|
|
Refractory chronic lymphocytic leukemia--new therapeutic strategies.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DRUG DERIVATIVE;
FLUDARABINE;
HISTONE DEACETYLASE INHIBITOR;
MONOCLONAL ANTIBODY;
VIDARABINE;
CHRONIC LYMPHATIC LEUKEMIA;
DRUG EFFECT;
DRUG RESISTANCE;
EXPERIMENTAL THERAPY;
HUMAN;
IMMUNOTHERAPY;
METHODOLOGY;
MORTALITY;
RECURRENT DISEASE;
REVIEW;
SURVIVAL;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
DRUG RESISTANCE, NEOPLASM;
HISTONE DEACETYLASE INHIBITORS;
HUMANS;
IMMUNOTHERAPY;
LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;
RECURRENCE;
SURVIVAL ANALYSIS;
THERAPIES, INVESTIGATIONAL;
VIDARABINE;
|
|
EID: 79957984650
PISSN: None
EISSN: 19492553
Source Type: Journal
DOI: 10.18632/oncotarget.184 Document Type: Review |
|
Times cited : (17)
|
|
References (0)
|
